Contineum Therapeutics, Inc. (CTNM)

NASDAQ: CTNM · Real-Time Price · USD

11.20

-0.56 (-4.76%)

Jan 15, 2026, 2:49 PM EST - Market open

Contineum Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan '26 Jan 15, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	409	378	-	-	-
Enterprise Value	223	164	-	-	-
Last Close Price	11.76	14.65	-	-	-
PB Ratio	1.90	1.91	-	-	-
P/TBV Ratio	2.22	1.91	-	-	-
Debt / Equity Ratio	0.03	0.03	0.01	0.15	0.08
Debt / EBITDA Ratio	-	-	0.03	-	-
Debt / FCF Ratio	-	-	0.03	-	-
Asset Turnover	-	-	0.55	-	-
Quick Ratio	28.68	20.53	22.83	6.26	18.78
Current Ratio	29.07	20.69	23.29	6.41	18.99
Return on Equity (ROE)	-30.40%	-26.19%	27.71%	-48.09%	-
Return on Assets (ROA)	-20.89%	-18.54%	11.10%	-23.44%	-
Return on Capital (ROIC)	-21.42%	-19.30%	11.79%	-25.44%	-
Return on Capital Employed (ROCE)	-36.90%	-25.10%	12.90%	-52.70%	-42.90%
Earnings Yield	-14.83%	-11.19%	-	-	-
FCF Yield	-13.19%	-8.83%	-	-	-
Buyback Yield / Dilution	-96.27%	-469.95%	-51.38%	-6.35%	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q